US Patent 7884113 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
Patent 7884113 was granted and assigned to Bristol-Myers Squibb on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+64 characters)
Article
Patent abstract
The invention provides for compounds of formula I
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07884113 Tetrahydroquinoline derivatives as cannabinoid receptor modulators US Patent 7884113 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
Infobox
Patent Number
0788411300
Patent Number
788411300
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078841130
Date of Patent
February 8, 2011
0Patent Application Number
121086160
Date Filed
April 24, 2008
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078841130
Date of Patent
February 8, 2011
0Patent Application Number
121086160
Date Filed
April 24, 2008
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07884113 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07884113
Date of patent
February 8, 2011
Patent application number
12108616
Date Filed
April 24, 2008
Patent primary examiner
Find more entities like US Patent 7884113 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
